Global Healthcare Analyst

Tina Banerjee

Equity research analyst having 15+ years of experience, with an interest on fundamentally strong global healthcare companies. I have been helping investors to find future winners in healthcare space to grow their wealth by focusing on the strength and potential of the business models of the companies. My initiating coverage reports and pitch help investors to know ‘what to buy’, ‘why to buy’, and ‘when to buy’. My clients always remain on top of the sector with the help of my timely and detailed notes on earnings or any news update. I also provide broader view on the entire healthcare sector through periodic thematic reports.

Orkla India IPO Review: Strong Brands and Valuations Are Not Too Spicy

Equity Capital Markets

Orkla India Ltd. / Equity Capital Markets

<ul>
<li>Orkla India filed for IPO to sell shares worth INR16.7B. It is an “offer for sale” by the selling shareholders intending to sell 22.8M shares at INR 695-730 per share.</li>
<li>Orkla is a multi-category Indian food company with key product categories being Spices and Convenience Foods under two major brands, MTR and Eastern.</li>
<li>The IPO offer price range appears to be a more reasonable for the company considering the fact that it lags behind on many fronts when compared to its’ peers.</li>
</ul>


Orkla India filed for IPO to sell shares worth INR16.7B. It is an “offer for sale” by the selling shareholders intending to sell 22.8M shares at INR 695-730 per share.
Orkla is a multi-category Indian food company with key product categories being Spices and Convenience Foods under two major brands, MTR and Eastern.
The IPO offer price range appears to be a more reasonable for the company considering the fact that it lags behind on many fronts when compared to its’ peers.


Orkla India IPO: Reasonable Price Package; Need to Break the South Barrier to Spice Up Future Growth